Education
About Us
Working with TipRanks
Follow Us
Qiagen NV (QGEN)
NYSE:QGEN
QGEN Stock Chart & Stats
$46.94
$0.22(0.49%)
At close: 4:00 PM EST
$46.94
$0.22(0.49%)
Day’s Range― - ―
52-Week Range$37.63 - $51.88
Previous CloseN/A
Volume260.87K
Average Volume (3M)1.15M
Market Cap
$10.18B
Enterprise Value$10.20B
Total Cash (Recent Filing)$1.69B
Total Debt (Recent Filing)$2.13B
Price to Earnings (P/E)25.3
Beta0.59
Next Earnings
Feb 10, 2026EPS Estimate
0.6Last Dividend Ex-Date
Jul 02, 2025Dividend Yield3.19%
Share Statistics
EPS (TTM)0.61
Shares Outstanding216,841,000
10 Day Avg. Volume1,057,166
30 Day Avg. Volume1,154,231
Financial Highlights & Ratios
PEG Ratio-1.59
Price to Book (P/B)2.78
Price to Sales (P/S)5.01
P/FCF Ratio19.58
Enterprise Value/Market Cap1.00
Enterprise Value/Revenue4.92
Enterprise Value/Gross Profit7.80
Enterprise Value/Ebitda12.52
Forecast
1Y Price Target
$49.42Price Target Upside5.28% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13
EPS Forecast (FY)2.36
Revenue Forecast (FY)$2.08B
Bulls Say, Bears Say
Bulls Say
Capital DeploymentQGEN continues to be proactive on capital deployment and the Q3 beat stemming from Sample Tech and Genomics highlights the benefits of QGEN's defensive, diversified portfolio.
Share RepurchaseA $500 million synthetic share purchase was announced, reflecting confidence in the company's valuation.
Strategic ExpansionThe company announced the acquisition of Parse, showcasing strategic expansion efforts.
Bears Say
External Factors ImpactOngoing government shutdown and other external factors are impacting confidence in achieving long-term revenue growth targets.
Growth DriversKey long-term growth drivers showed signs of softness in the quarter, and management commentary regarding organic growth was mixed.
Valuation UncertaintyCurrent valuation reflects uncertainty, with shares trading at 17 times 2026 earnings.
Qiagen News
QGEN FAQ
What was Qiagen NV’s price range in the past 12 months?
Qiagen NV lowest stock price was $37.63 and its highest was $51.88 in the past 12 months.
What is Qiagen NV’s market cap?
Qiagen NV’s market cap is $10.18B.
When is Qiagen NV’s upcoming earnings report date?
Qiagen NV’s upcoming earnings report date is Feb 10, 2026 which is in 68 days.
How were Qiagen NV’s earnings last quarter?
Qiagen NV released its earnings results on Nov 04, 2025. The company reported $0.61 earnings per share for the quarter, beating the consensus estimate of $0.585 by $0.025.
Is Qiagen NV overvalued?
According to Wall Street analysts Qiagen NV’s price is currently Undervalued.
Does Qiagen NV pay dividends?
Qiagen NV pays a Semiannually dividend of $0.25 which represents an annual dividend yield of 3.19%. See more information on Qiagen NV dividends here
What is Qiagen NV’s EPS estimate?
Qiagen NV’s EPS estimate is 0.6.
How many shares outstanding does Qiagen NV have?
Qiagen NV has 216,841,000 shares outstanding.
What happened to Qiagen NV’s price movement after its last earnings report?
Qiagen NV reported an EPS of $0.61 in its last earnings report, beating expectations of $0.585. Following the earnings report the stock price went down -0.249%.
Which hedge fund is a major shareholder of Qiagen NV?
Currently, no hedge funds are holding shares in QGEN
Qiagen Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$49.42 (5.28% Upside)
$49.42 (5.28% Upside)
Blogger Sentiment
Neutral
QGEN Sentiment 50%
Sector Average 68%
Sector Average 68%
Hedge Fund Trend
Decreased
By 49.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days ▼ 1.1%
Last 30 Days ▲ 2.7%
Last 30 Days ▲ 2.7%
Technicals
SMA
Positive
20 days / 200 days
Momentum
9.58%
12-Months-Change
Fundamentals
Return on Equity
11.29%
Trailing 12-Months
Asset Growth
4.52%
Trailing 12-Months
Company Description
Qiagen NV
Qiagen N.V. is a global leader in the development and production of innovative sample and assay technologies, providing solutions for the extraction, purification, and analysis of nucleic acids and proteins. The company operates in the molecular diagnostics, life sciences research, and pharmaceutical sectors, offering a wide range of products including sample preparation kits, assay technologies, and bioinformatics tools. Qiagen's offerings are essential for various applications such as clinical diagnostics, academic research, and drug development, making it a pivotal player in the biotechnology landscape.
QGEN Company Deck
QGEN Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
QIAGEN demonstrated strong and consistent performance, with significant achievements in strategic initiatives, financial growth, and product segment performance. Despite challenges such as the U.S. government shutdown, headwinds from currency and tariffs, and regional sales declines, the company's positive trajectory and future growth plans contribute to an overall positive sentiment.View all QGEN earnings summariesQGEN Stock 12 Month Forecast
Average Price Target
$49.42
▲(5.28% Upside)
Technical Analysis
Ownership Overview
0.51% Insiders
19.53% Mutual Funds
7.62% Other Institutional Investors
53.16% Public Companies and
Individual Investors